Physician profile
Danny Warda
NPI 1962031179
$4,625.46
in general payments reported to CMS, 2019-2025
8 companies · $4,379 in 2025
The $4,379 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.77 · 2024: $235 · 2025: $4,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,095 · Food and Beverage: $1,382 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,094.66 |
| Food and Beverage | $1,382.02 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,552.29 | 2024-2025 | Inhance, Stratafix |
| Axogen | $1,511.05 | 2025 | |
| Trimed, INC. | $946.20 | 2025 | Tools - Wfs |
| Depuy Synthes Sales INC. | $359.53 | 2024-2025 | Dynacord, Truespan Orthocord, Healix Knotless Peek |
| Polynovo North America LLC | $157.20 | 2025 | Novosorb Btm |
| Medtronic, INC. | $34.14 | 2022-2025 | Mazor X System |
| United Orthopedics LLC | $33.74 | 2024 | |
| Stryker Corporation | $31.31 | 2024 | Aequalis Perform, Aequalis Perform Reversed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Warda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.